section name header

Pronunciation ⬇

a-DAP-a-leen

Classifications ⬆ ⬇

Therapeutic Classification: antiacne agents

Pharmacologic Classification: retinoids

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Binds to retinoic acid nuclear receptors resulting in decreased microcomedone formation.
Therapeutic effects:
  • Reduction in inflammatory and noninflammatory acne lesions.

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption occurs with limited surface-area application.

Distribution: Unknown.

Metabolism/Excretion: Excreted via the biliary route.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(improved skin appearance)

ROUTEONSETPEAKDURATION
Topical8–12 wkunknownunknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Differin